Articles dans des revues avec comité de lecture (210)

  1. 60. Lupinacci, R. M., Cervera, P., Scriva, A., Dumont, S., Hammel, P., Sauvanet, A., Louvet, C., Delpero, J. R., Paye, F., Vaillant, J.-C., André, T., Goloudina, A., Closset, J., Emile, J.-F., Van Laethem, J.-L., Jonchère, V., Abd Alsamad, I., Antoine, M., Rodenas, A., Fléjou, J. F., Dusetti, N., Iovanna, J.-L., Buhard, O., Duval, A., Svrcek, M., Bachet, J.-B., Marechal, R., Demetter, P., Cros, J., Bardier-Dupas, A., & Collura, A. (2018). Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Gastroenterology, 154(4), 1061-1065. doi:10.1053/j.gastro.2017.11.009
  2. 61. Bohlok, A., Khoury, M. E., Tulelli, B., Verset, L., Zaarour, A., Demetter, P., Eisendrath, P., & El Nakadi, I. (2018). A rare presentation of IgG4 related disease as a gastric antral lesion: Case report and review of the literature. International Journal of Surgery Case Reports, 51, 244-247. doi:10.1016/j.ijscr.2018.08.065
  3. 62. Georges, L. M., Verset, L., Zlobec, I., Demetter, P., & De Wever, O. (2018). Impact of the Microenvironment on Tumour Budding in Colorectal Cancer. Advances in experimental medicine and biology, 1110, 101-111. doi:10.1007/978-3-030-02771-1_7
  4. 63. Hubert, C., Lucidi, V., Weerts, J., Dili, A., Demetter, P., Massart, B., Komuta, M., Navez, J., Reding, R., Gigot, J. F., & Sempoux, C. (2018). Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases. European journal of surgical oncology, 44(10), 1532-1538. doi:10.1016/j.ejso.2018.07.050
  5. 64. Tommelein, J., De Vlieghere, E., Verset, L., Melsens, E., Leenders, J., Descamps, B., Debucquoy, A., Vanhove, C., Pauwels, P., Gespach, C. P., Vral, A., De Boeck, A., Haustermans, K., de Tullio, P., Ceelen, W., Demetter, P., Boterberg, T., Bracke, M., & De Wever, O. (2017). Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation. Cancer research, 78(3), 659-670. doi:10.1158/0008-5472.CAN-17-0524
  6. 65. Veereman-Wauters, G., Vlayen, J., Robays, J., Fairon, N., Stordeur, S., Rolfo, C., Bielen, D. J. L. E. D., Bols, A., Demetter, P., D'Hoore, A., Haustermans, K. M. G. K., Hendlisz, A., Lemmers, A., Leonard, D., Penninckx, F. M. A. F., Van Cutsem, E., & Peeters, M. (2017). Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard? Critical reviews in oncology/hematology, 114, 43-52. doi:10.1016/j.critrevonc.2017.03.008
  7. 66. Vandenberghe, P., Hague, P., Hockman, S. S., Manganiello, V. V., Demetter, P., Erneux, C., & Vanderwinden, J.-M. (2017). Phosphodiesterase 3A: a new player in development of interstitial cells of Cajal and a prospective target in gastrointestinal stromal tumors (GIST). Oncotarget. doi:10.18632/oncotarget.17010
  8. 67. Verset, L., Tommelein, J., Decaestecker, C., De Vlieghere, E., Bracke, M., Salmon, I., De Wever, O., & Demetter, P. (2017). ADAM-17/FHL2 Colocalisation Suggests Interaction and Role of These Proteins in Colorectal Cancer. Tumor biology, 39(3), 1010428317695024. doi:10.1177/1010428317695024
  9. 68. Demetter, P., & Verset, L. (2017). Benign, premalignant and malignant pancreatic cystic lesions: The pathology landscape. Acta Gastro-Enterologica Belgica (English ed.), 80(2), 293-298.
  10. 69. Chiavarina, B., Nokin, M. J., Bellier, J., Durieux, F., Bletard, N., Sherer, F., Lovinfosse, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P. O., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-mediated stress correlates with high metabolic activity and promotes tumor growth in colorectal cancer. International journal of molecular sciences, 18(1), 213. doi:10.3390/ijms18010213
  11. 70. Drouillard, A., Puleo, F., Bachet, J.-B., Ouazzani, S., Calomme, A., Demetter, P., Verset, G., Van Laethem, J.-L., & Marechal, R. (2016). DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. British Journal of Cancer, 115(10), 1245-1252. doi:10.1038/bjc.2016.319
  12. 71. Puleo, F., Demetter, P., Eisendrath, P., Marechal, R., Verset, L., Toussaint, E., Bachet, J.-B., Arvanitakis, M., Mostafa, I., Devière, J., & Van Laethem, J.-L. (2016). Feasibility of Immunohistochemistry on Endoscopic Ultrasound Fine-Needle Aspiration Samples for Evaluating Predictive Biomarkers in Pancreatic Cancer Management. Pancreas, 45(9), e50-e52. doi:10.1097/MPA.0000000000000672

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>